美股期权个股详情

ACAD240517C27000

添加自选

0.08
0.000.00%

延时15分钟行情收盘价 05/06 09:30 (美东)

0.00最高价0.00最低价

阿卡迪亚股票讨论

登录发表评论

Meltyy

05/16 14:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$因塞特(INCY.US)$
$百济神州(BGNE.US)$
$阿卡迪亚(ACAD.US)$
$Madrigal Pharmaceuticals(MDGL.US)$
$Rhythm Pharmaceuticals(RYTM.US)$
$Revolution Medicines(RVMD.US)$
$Kymera Therapeutics(KYMR.US)$
$AbCellera Biologics(ABCL.US)$
$Bicycle Therapeutics(BCYC.US)$
$Edgewise Therapeutics(EWTX.US)$
$Immunocore(IMCR.US)$
$Kodiak Sciences(KOD.US)$
$Roivant Sciences(ROIV.US)$
...

Moomoo AI

03/28 02:28

Analysts have high confidence in ACADIA Pharmaceuticals, predicting an average annual growth rate of 42%. The company's lack of debt reduces concerns around repayments and makes it a less risky investment.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) On The Verge Of Breaking Even

SOARMAN

03/12 17:47

Several companies were in the spotlight due to various developments:
Oracle ( $甲骨文(ORCL.US)$ ) experienced a surge in after-hours trading, buoyed by cloud deals and AI demand.
Acadia Pharmaceuticals ( $阿卡迪亚(ACAD.US)$ ) saw its stock decline by 15% following the announcement of disappointing results from a Phase 3 trial.
Vail Resorts ( $Vail Resorts(MTN.US)$ ) reported a decrease in stock value after releasing results that were impacted by lower visits and snowfall.
$阿莎娜(ASAN.US)$ Asana rep...

Trytosaveabit

03/12 04:37

$阿卡迪亚(ACAD.US)$ And where will the bottom be? Could it be a opportunity? Time will tell? Hehehe

Trytosaveabit

03/12 04:09

Ouch! I’m seeing a drop coming?

$阿卡迪亚(ACAD.US)$ Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced top-line results from the Phase 3 ADVANCE-2 trial evaluating pimavanserin for the treatment of negative symptoms of schizophrenia. Pimavanserin did not demonstrate a statistically significant improvement over placebo on the study's primary endpoint, the change from baseline to week 26 on the Negative Symptom Assessment-16 (NSA-16) total score (-11.8 vs. -11.1; p=0.4825; effe...

Trytosaveabit

03/12 04:03

T 1 News halt

$阿卡迪亚(ACAD.US)$ Looking for FDA news here?

Meltyy

03/04 17:54

🎯 Ph 3 readouts in Q1 2024...

$辉瑞(PFE.US)$ Phase 3
$BioCardia(BCDA.US)$ Phase 3
$Atea Pharmaceuticals(AVIR.US)$ Phase 3
$Crinetics(CRNX.US)$ Phase 3
$Axsome Therapeutics(AXSM.US)$ Phase 3
$罗氏(ADR)(RHHBY.US)$ Phase 3
$阿卡迪亚(ACAD.US)$ Phase 3
$Sellas Life Sciences(SLS.US)$ Phase 3
$Aquestive Therapeutics(AQST.US)$ Phase 3
$Jaguar Health(JAGX.US)$ Phase 3
$Novocure(NVCR.US)$ Phase 3
$强生(JNJ.US)$ Phase 3

Meltyy

02/22 12:05

Biotech Stock Catalyst Watchlist

🎯 Ph 3 readouts in Q1 2024...
$辉瑞(PFE.US)$ Phase 3
$Palatin Technologies(PTN.US)$ Phase 3
$Annovis Bio(ANVS.US)$ Phase 3
$BioCardia(BCDA.US)$ Phase 3
$Atea Pharmaceuticals(AVIR.US)$ Phase 3
$Ironwood医药(IRWD.US)$ Phase 3
$阿里拉姆制药(ALNY.US)$ Phase 3
$Axsome Therapeutics(AXSM.US)$ Phase 3
$ $Novocure(NVCR.US)$ Phase 3
$罗氏(ADR)(RHHBY.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$阿卡迪亚(ACAD.US)$ Phase 3
$Sellas Life Sciences(SLS.US)$...

Moomoo AI

02/06 21:30

ACADIA Pharmaceuticals Inc.'s low P/S ratio is due to its poor revenue outlook. Investors' gloomy expectations for future revenue growth are driving the low P/S ratio. These conditions will persist as a hurdle for the share price unless improved.

Lacklustre Performance Is Driving ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Low P/S

Meltyy

02/01 04:38

Ph 3 readouts in Q1 2024...

$辉瑞(PFE.US)$ Phase 3
$Regenxbio(RGNX.US)$ Phase 3
$Annovis Bio(ANVS.US)$ Phase 3
$Atea Pharmaceuticals(AVIR.US)$ Phase 3
$Ironwood医药(IRWD.US)$ Phase 3
$阿里拉姆制药(ALNY.US)$ Phase 3
$福泰制药(VRTX.US)$ Phase 3
$KalVista Pharmaceuticals(KALV.US)$ Phase 3
$Axsome Therapeutics(AXSM.US)$ Phase 3
$Novocure(NVCR.US)$ Phase 3
$罗氏(ADR)(RHHBY.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$Applied Therapeutics(APLT.US)$ Phase 3
$阿卡迪亚(ACAD.US)$ Phase 3...

暂无评论